Imerys Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Imerys heeft een totaal eigen vermogen van €3.2B en een totale schuld van €2.4B, wat de schuld-eigenvermogensverhouding op 74.5% brengt. De totale activa en totale passiva bedragen respectievelijk €7.2B en €4.0B. De EBIT Imerys is €253.9M waardoor de rentedekking 8.4 is. Het heeft contanten en kortetermijnbeleggingen van €605.9M.

Belangrijke informatie

74.5%

Verhouding schuld/eigen vermogen

€2.40b

Schuld

Rente dekkingsratio	8.4x
Contant	€605.90m
Aandelen	€3.22b
Totaal verplichtingen	€3.96b
Totaal activa	€7.19b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €2.7B ) IY4 } overtreffen de korte termijn passiva ( €1.6B ).

Langlopende schulden: De kortetermijnactiva IY4 ( €2.7B ) overtreffen de langetermijnschulden ( €2.4B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 55.7% ) IY4 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van IY4 is de afgelopen 5 jaar gedaald van 76.9% naar 74.5%.

Schuldendekking: De schuld van IY4 wordt goed gedekt door de operationele kasstroom ( 22.9% ).

Rentedekking: De rentebetalingen op de schuld van IY4 worden goed gedekt door EBIT ( 8.4 x dekking).

Imerys Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Third quarter 2024 earnings released

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

New minor risk - Financial position

Second quarter 2024 earnings released

Upcoming dividend of €1.35 per share

Imerys S.A. to Report Q2, 2024 Results on Jul 29, 2024

First quarter 2024 earnings released

Imerys Enters into Exclusive Negotiations for the Sale of its Assets Serving the Paper Market

Full year 2023 earnings released: EPS: €0.076 (vs €2.04 in FY 2022)

Mytilineos S.A. (ATSE:MYTIL) acquired IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK).

Investor sentiment improves as stock rises 19%

Now 33% overvalued after recent price rise

Imerys S.A. to Report Q1, 2024 Results on Apr 30, 2024

Imerys S.A. to Report Fiscal Year 2023 Results on Feb 21, 2024

Mytilineos S.A. (ATSE:MYTIL) signed an agreement to acquire IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK) for €10 million.

Mytilineos is in Advanced Negotiations to Acquire Imerys Bauxite Greece

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Upcoming dividend of €3.85 per share at 4.3% yield

First quarter 2023 earnings released: EPS: €0.73 (vs €0.86 in 1Q 2022)

Full year 2022 earnings released: EPS: €1.89 (vs €2.84 in FY 2021)

Imerys S.A. to Report Q1, 2023 Results on May 02, 2023

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) in a transaction valued at approximately €930 million.

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) for approximately €930 million.

High number of new directors

Third quarter 2022 earnings released

Imerys S.A. to Report Fiscal Year 2022 Results on Feb 16, 2023

Platinum Equity Advisors, LLC acquired CALDERYS France S.A.S. from Imerys S.A. (ENXTPA:NK).

Imerys S.A. Announces Executive Appointments

CIMBAR Performance Minerals, Inc. acquired Sahuarita Arizona operation of Imerys.

Imerys Introduces ImerShield Solutions

Second quarter 2022 earnings released: EPS: €1.41 (vs €0.82 in 2Q 2021)

High number of new directors

Upcoming dividend of €1.55 per share

Northern Graphite Corporation (TSXV:NGC) completed the acquisition of Okanjande graphite deposit in Namibia from Imerys S.A. (ENXTPA:NK).

First quarter 2022 earnings released: EPS: €0.86 (vs €0.85 in 1Q 2021)

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: EPS €0.89 (vs €0.48 in 3Q 2020)

Imerys S.A. (ENXTPA:NK) commences an Equity Buyback Plan for 8,494,095 shares, representing 10% of its issued share capital, under the authorization approved on May 10, 2021.

Second quarter 2021 earnings released: EPS €0.82 (vs €0.16 in 2Q 2020)

Upcoming dividend of €1.15 per share

First quarter 2021 earnings released: EPS €0.85 (vs €0.56 in 1Q 2020)

New 90-day high: €45.10

Revenue beats expectations

Full year 2020 earnings released: EPS €0.37 (vs €1.53 in FY 2019)

Imerys S.A. to Report Fiscal Year 2020 Results on Feb 18, 2021

New 90-day high: €41.98

New 90-day high: €38.72

New 90-day high: €37.56

New 90-day high: €35.56

Imerys S.A. (ENXTPA:NK) acquired Sunward Refractories Co., Ltd.

Revenue misses expectations

New 90-day low: €29.98

Imerys USA Inc. completed the acquisition of Kentucky-Tennessee Clay Co. from Hecla Mining.

Imerys S.A. to Report Q1, 2021 Results on Apr 29, 2021

Imerys S.A. (ENXTPA:NK) signed an agreement to acquire 60% stake in Haznedar Refrakter Sanayii A.S.

New 90-day high - €35.38

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven